Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
Conditions: Non-Hodgkin's Lymphoma (NHL); Peripheral T Cell Lymphoma (PTCL) Intervention: Biological: Ex-vivo expanded allogeneic γδT cells Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing GD Initiative Cell Therapy Technology Co.,Ltd.; Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2021 Category: Research Source Type: clinical trials
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Conditions: Acute Myeloid Leukemia; Non-hodgkin's Lymphoma; Multiple Myeloma Intervention: Drug: CD70 CAR T-cells Sponsors: Zhejiang University; Yake Biotechnology Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials